Invention Grant
- Patent Title: Selective histone deacetylase inhibitors for the treatment of human disease
-
Application No.: US16959570Application Date: 2019-01-08
-
Publication No.: US11407723B2Publication Date: 2022-08-09
- Inventor: Scott Grindrod , Mira Jung , Anatoly Dritschilo
- Applicant: Shuttle Pharmaceuticals, Inc.
- Applicant Address: US MD Rockville
- Assignee: Shuttle Pharmaceuticals, Inc.
- Current Assignee: Shuttle Pharmaceuticals, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Morgan, Lewis & Bockius, LLP
- International Application: PCT/US2019/012770 WO 20190108
- International Announcement: WO2019/139921 WO 20190718
- Main IPC: C07D285/135
- IPC: C07D285/135 ; C07C237/20 ; A61K45/06
Abstract:
Selective HDAC inhibitors, and pharmaceutical compositions that include the same, are described herein for the treatment of cancer, immunological diseases, inflammatory diseases, and neurological diseases.
Public/Granted literature
- US20210078963A1 SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE Public/Granted day:2021-03-18
Information query
